Γ—

Tag: David Sinclair

ARDD Crowd
Once a year, Copenhagen becomes a Mecca for the longevity community. Hundreds of people flock to the picturesque Danish capital to attend the Aging Research and Drug Discovery Meeting (ARDD) for five full days of talks by geroscientists and biotech leaders, mingling and networking with like-minded longevity enthusiasts, and not-so-healthy late night-outs. ARDD is organized...
LSN Age Reversal Pill
For this episode of Lifespan News, Emmett Short talks about David Sinclair's serious effort to epigenetically rejuvenate cells by using small molecules, which would lead to the creation of a genuine age reversal pill. This technology could be significantly cheap and simple to produce, to the point that high school student could make it in...
A team led by renowned Harvard geroscientists David Sinclair and Vadim Gladyshev has reported successful chemically induced partial cellular reprogramming in vitro. The researchers have also developed a novel cellular rejuvenation assay [1]. Smaller than proteins Complete cellular reprogramming using the Yamanaka factors was first accomplished more than ten years ago [2]. Those four proteins,...
Academy for Health and Lifespan Research
New York, June 14th, 2023 – The Academy for Health and Lifespan Research (AHLR) is proud to announce the election of Dr. David Sinclair as its new President. Dr. Sinclair, a distinguished Professor of Genetics at Harvard Medical School and renowned author of the New York Times Bestseller "Lifespan," has been chosen by his peers...
Life Biosciences
Life Biosciences, a company co-founded by the well-known Dr. David Sinclair, has recently claimed that it has reversed a form of neuropathy in nonhuman primates through gene therapy and epigenetic reprogramming. The full press release is included here. Life Biosciences, a biotechnology company advancing innovative cellular rejuvenation technologies to reverse diseases of aging and injury...
Sinclair Why We Age
David Sinclair, PhD, esteemed molecular geneticist at Harvard, believes that aging is a disease that should be attacked at its roots. Furthermore, he believes if we are to make efficient and sensible use our medical resources, we must move away from the "whack-a-mole" approach to treating individual age-related diseases. In his first book, Lifespan: Why...